Delivery Order SPE2DB22D2214-SPE2DB24FS6FE

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $45K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,770.89 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a $3,694.32 Firm Fixed Price Delivery Order contract to supply HUMIRA(CF) PEN 40 MG/0.4 MLS. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for military treatment...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract valued at $13,901.54 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a $11,082.96 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. This delivery order was placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for a broad range of medical commodities to support military treatment programs...
The U.S. Defense Logistics Agency (DLA) awarded a $1,199.08 Firm Fixed Price delivery order to Amerisourcebergen Drug Corp. The order, which has an ultimate completion date of October 15, 2024, is for 4566086883 - HUMIRA PEN 40 MG/0.8 MLS. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military...
The U.S. Defense Logistics Agency (DLA) awarded a $5,344.82 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division to supply 4,565,058,929 units of the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $4,098.96 to AmerisourceBergen Drug Corp's Corporate Office Division on May 20, 2024. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide...
The U.S. Defense Logistics Agency (DLA) awarded a $1,794.38 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract has an ultimate completion date of August 15, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies through an existing Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical. This IDC...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $2,770.74 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a Firm Fixed Price delivery order contract valued at $7,366.52 for the supply of HUMIRA PEN 40MG.4ML 2S. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA and Amerisourcebergen, valued up to $999,999,999.00, for the provision of a comprehensive range of pharmaceutical products and medical supplies to support the Department...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB24FS6FE
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office division a $45,349.28 firm-fixed-price delivery order contract for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is expected to be completed by August 13, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply critical medical supplies and pharmaceuticals to various defense and civilian agencies.

Generated 11/11/24, 9:16 AM